These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8138805)

  • 1. Decrease of nerve Na+,K(+)-ATPase activity in the pathogenesis of human diabetic neuropathy.
    Scarpini E; Bianchi R; Moggio M; Sciacco M; Fiori MG; Scarlato G
    J Neurol Sci; 1993 Dec; 120(2):159-67. PubMed ID: 8138805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoneurial ATPase activity in Tangier disease and other peripheral neuropathies.
    Sutherland WH; Pollock M
    Muscle Nerve; 1984; 7(6):447-53. PubMed ID: 6152683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothesis: low Na/K-ATPase activity in the red cell membrane, a potential marker of the predisposition to diabetic neuropathy.
    Raccah D; Gallice P; Pouget J; Vague P
    Diabete Metab; 1992; 18(3):236-41. PubMed ID: 1327887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genetic factors, Na K ATPase activity and neuropathy in diabetics].
    Vague P; Dufayet D; Lamotte MF; Mouchot C; Raccah D
    Bull Acad Natl Med; 1997 Dec; 181(9):1811-21; discussion 1821-3. PubMed ID: 9611401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic neuropathy in db/db mice develops independently of changes in ATPase and aldose reductase. A biochemical and immunohistochemical study.
    Bianchi R; Marelli C; Marini P; Fabris M; Triban C; Fiori MG
    Diabetologia; 1990 Mar; 33(3):131-6. PubMed ID: 2158468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between red blood cell Na/K-ATPase activities and diabetic complications in patients with type 2 diabetes mellitus.
    Koc B; Erten V; Yilmaz MI; Sonmez A; Kocar IH
    Endocrine; 2003 Aug; 21(3):273-8. PubMed ID: 14515013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro correction of impaired Na+-K+-ATPase in diabetic nerve by protein kinase C agonists.
    Lattimer SA; Sima AA; Greene DA
    Am J Physiol; 1989 Feb; 256(2 Pt 1):E264-9. PubMed ID: 2537578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of diabetic neuropathy with Na/K ATPase gene polymorphism.
    Vague P; Dufayet D; Coste T; Moriscot C; Jannot MF; Raccah D
    Diabetologia; 1997 May; 40(5):506-11. PubMed ID: 9165217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cilostazol on development of experimental diabetic neuropathy: functional and structural studies, and Na+ -K+ -ATPase acidity in peripheral nerve in rats with streptozotocin-induced diabetes.
    Naka K; Sasaki H; Kishi Y; Furuta M; Sanke T; Nanjo K; Mukoyama M
    Diabetes Res Clin Pract; 1995 Dec; 30(3):153-62. PubMed ID: 8861454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of Na,K-ATPase isoenzymes in the rat diabetic neuropathy: protective effect of dietary supplementation with n-3 fatty acids.
    Gerbi A; Maixent JM; Barbey O; Jamme I; Pierlovisi M; Coste T; Pieroni G; Nouvelot A; Vague P; Raccah D
    J Neurochem; 1998 Aug; 71(2):732-40. PubMed ID: 9681464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-peptide, Na+,K(+)-ATPase, and diabetes.
    Vague P; Coste TC; Jannot MF; Raccah D; Tsimaratos M
    Exp Diabesity Res; 2004; 5(1):37-50. PubMed ID: 15198370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein kinase C agonists acutely normalize decreased ouabain-inhibitable respiration in diabetic rabbit nerve. Implications for (Na,K)-ATPase regulation and diabetic complications.
    Greene DA; Lattimer SA
    Diabetes; 1986 Feb; 35(2):242-5. PubMed ID: 3002888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythrocyte Na(+)-K(+)-ATPase activity, metabolic control, and neuropathy in IDDM patients.
    Raccah D; Fabreguetts C; Azulay JP; Vague P
    Diabetes Care; 1996 Jun; 19(6):564-8. PubMed ID: 8725852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Na,K-atpase alterations in diabetic rats: relationship with lipid metabolism and nerve physiological parameters.
    Djemli-Shipkolye A; Coste T; Raccah D; Vague P; Pieroni G; Gerbi A
    Cell Mol Biol (Noisy-le-grand); 2001 Mar; 47(2):297-304. PubMed ID: 11355004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normalization of Na(+)-K(+)-ATPase activity in isolated membrane fraction from sciatic nerves of streptozocin-induced diabetic rats by dietary myo-inositol supplementation in vivo or protein kinase C agonists in vitro.
    Kim J; Kyriazi H; Greene DA
    Diabetes; 1991 May; 40(5):558-67. PubMed ID: 1850704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between neuropathy, hypertension and red blood cell Na/K ATPase in patients with insulin-dependent diabetes mellitus.
    Jannot MF; Raccah D; Dufayet de la Tour D; Coste T; Gouvernet J; Vague P
    Diabetes Metab; 1999 Mar; 25(1):35-42. PubMed ID: 10335422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of oxidative stress in experimental diabetic neuropathy].
    Wang L; Zheng KJ; Dong DY; Sun Y; Wang YM
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2008 Feb; 24(1):108-11. PubMed ID: 21141571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Disorders of sorbitol and myoinositol metabolism and the activity of sodium, potassium ATPase in the pathogenesis of peripheral neuropathy in patients with diabetes mellitus].
    Mosiewicz J; Grzywa M
    Pol Tyg Lek; 1992 Jan 6-13; 47(1-2):56-8. PubMed ID: 1329048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased Na/K ATPase ouabain binding sites in red blood cells of patients with insulin-dependent diabetes and healthy north African control subjects: relationship with diabetic neuropathy.
    Raccah D; Dadoun F; Coste T; Vague P
    Horm Metab Res; 1996 Mar; 28(3):128-32. PubMed ID: 8926011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of aldose reductase inhibitor (Ponalrestat) on erythrocyte Na,K-ATPase activity in non-insulin-dependent diabetic patients with polyneuropathy.
    Umeda F; Noda K; Hashimoto T; Yamashita T; Nawata H
    Diabetes Res; 1989 Nov; 12(3):125-9. PubMed ID: 2561396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.